SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-159076
Filing Date
2022-05-25
Accepted
2022-05-25 07:31:10
Documents
41
Period of Report
2022-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d308740d8k.htm   iXBRL 8-K 24439
2 EX-99.1 d308740dex991.htm EX-99.1 33571
6 GRAPHIC g308740ex99_1p10g1.jpg GRAPHIC 299341
7 GRAPHIC g308740ex99_1p11g1.jpg GRAPHIC 305152
8 GRAPHIC g308740ex99_1p12g1.jpg GRAPHIC 283630
9 GRAPHIC g308740ex99_1p13g1.jpg GRAPHIC 340844
10 GRAPHIC g308740ex99_1p14g1.jpg GRAPHIC 378512
11 GRAPHIC g308740ex99_1p15g1.jpg GRAPHIC 194833
12 GRAPHIC g308740ex99_1p16g1.jpg GRAPHIC 173742
13 GRAPHIC g308740ex99_1p17g1.jpg GRAPHIC 242676
14 GRAPHIC g308740ex99_1p18g1.jpg GRAPHIC 330356
15 GRAPHIC g308740ex99_1p19g1.jpg GRAPHIC 280964
16 GRAPHIC g308740ex99_1p1g1.jpg GRAPHIC 187881
17 GRAPHIC g308740ex99_1p20g1.jpg GRAPHIC 310420
18 GRAPHIC g308740ex99_1p21g1.jpg GRAPHIC 157051
19 GRAPHIC g308740ex99_1p22g1.jpg GRAPHIC 204603
20 GRAPHIC g308740ex99_1p23g1.jpg GRAPHIC 383035
21 GRAPHIC g308740ex99_1p24g1.jpg GRAPHIC 219508
22 GRAPHIC g308740ex99_1p25g1.jpg GRAPHIC 305495
23 GRAPHIC g308740ex99_1p26g1.jpg GRAPHIC 256494
24 GRAPHIC g308740ex99_1p27g1.jpg GRAPHIC 238203
25 GRAPHIC g308740ex99_1p28g1.jpg GRAPHIC 149273
26 GRAPHIC g308740ex99_1p2g1.jpg GRAPHIC 632321
27 GRAPHIC g308740ex99_1p3g1.jpg GRAPHIC 326895
28 GRAPHIC g308740ex99_1p4g1.jpg GRAPHIC 272253
29 GRAPHIC g308740ex99_1p5g1.jpg GRAPHIC 256064
30 GRAPHIC g308740ex99_1p6g1.jpg GRAPHIC 238120
31 GRAPHIC g308740ex99_1p7g1.jpg GRAPHIC 369869
32 GRAPHIC g308740ex99_1p8g1.jpg GRAPHIC 217427
33 GRAPHIC g308740ex99_1p9g1.jpg GRAPHIC 375119
  Complete submission text file 0001193125-22-159076.txt   11117887

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aeri-20220525.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20220525_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20220525_pre.xml EX-101.PRE 11271
35 EXTRACTED XBRL INSTANCE DOCUMENT d308740d8k_htm.xml XML 3404
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 22958884
SIC: 2836 Biological Products, (No Diagnostic Substances)